Forcefield Therapeutics
PrivateLast Round
Series A
Jun 20, 2024
Total Funding Raised
$82.9M
Momentum
Top 50%
of companies Caplight tracks
Company Overview
Forcefield Therapeutics is a biotechnology company that develops therapeutics to protect heart function by arresting the loss of cardiomyocytes following myocardial infarction.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery
Business Model
B2B
Customer Profile
Services & Consulting, Data as a Service
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Forcefield Therapeutics Comparables
Compare Forcefield Therapeutics with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Infensa Bioscience | 84% | |
| SERCA Pharmaceuticals | 80% | |
| Heqet Therapeutics | 78% | |
Forcefield Therapeutics Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series A | Jun 20, 2024 | ||||
| Series A | Mar 28, 2024 | ||||
| Seed | Apr 25, 2022 |
Forcefield Therapeutics Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Roche Venture Fund | Series A |
| Syncona | Series A, Seed |
Market signals
Structured signals derived from secondary market and firmographic data.
- May 16, 2026
Monthly visitors grew 68% MoM.
- Jun 20, 2024
$38.1M round led by Syncona.
Forcefield Therapeutics Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Forcefield Therapeutics's valuation, stock price, and market status.